These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19306838)

  • 1. Correlations between in vitro potency of polyethylene glycol-protein conjugates and their chromatographic behavior.
    Caserman S; Kusterle M; Kunstelj M; Milunović T; Schiefermeier M; Jevsevar S; Porekar VG
    Anal Biochem; 2009 Jun; 389(1):27-31. PubMed ID: 19306838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and biologic characterization of pegylated recombinant IFN-alpha2b.
    Grace M; Youngster S; Gitlin G; Sydor W; Xie L; Westreich L; Jacobs S; Brassard D; Bausch J; Bordens R
    J Interferon Cytokine Res; 2001 Dec; 21(12):1103-15. PubMed ID: 11798469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillary electrophoretic separation of high-molecular-weight poly(ethylene glycol)-modified proteins.
    Na DH; Park EJ; Jo YW; Lee KC
    Anal Biochem; 2008 Feb; 373(2):207-12. PubMed ID: 17888863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon alpha-2b modified with polyethylene glycol].
    Wu Y; Zhai Y; Lei J; Ma G; Su Z
    Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1658-63. PubMed ID: 19160853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical and preparative separation of PEGylated lysozyme for the characterization of chromatography media.
    Moosmann A; Christel J; Boettinger H; Mueller E
    J Chromatogr A; 2010 Jan; 1217(2):209-15. PubMed ID: 19963219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.
    Ramon J; Saez V; Baez R; Aldana R; Hardy E
    Pharm Res; 2005 Aug; 22(8):1374-86. PubMed ID: 16078148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugation of PolyPEG to interferon alpha extends serum half-life while maintaining low viscosity of the conjugate.
    Podobnik B; Helk B; Smilović V; Škrajnar Š; Fidler K; Jevševar S; Godwin A; Williams P
    Bioconjug Chem; 2015 Mar; 26(3):452-9. PubMed ID: 25629733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the ion exchange chromatography for matrix-assisted PEGylation and purification of consensus interferon.
    Bajwa F; Ahmed N; Khan MA; Azam F; Akram M; Tahir S; Zafar AU
    Biotechnol Appl Biochem; 2020 Mar; 67(2):196-205. PubMed ID: 31589775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of PEGylated proteins, with the example of PEGylated lysozyme and PEGylated scFv.
    Moosmann A; Müller E; Böttinger H
    Methods Mol Biol; 2014; 1129():527-38. PubMed ID: 24648098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylation and Cell Based Bioassay of Human Interferon-α2b Along its Docking Studies and Effect on Plasma Half-Life.
    Shahzadi SK; Qadir MA; Mahmood N; Ahmed M
    Protein Pept Lett; 2020; 27(3):219-224. PubMed ID: 31612813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-phase PEGylation of recombinant interferon alpha-2a for site-specific modification: process performance, characterization, and in vitro bioactivity.
    Lee BK; Kwon JS; Kim HJ; Yamamoto S; Lee EK
    Bioconjug Chem; 2007; 18(6):1728-34. PubMed ID: 17941681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the major positional isomer of pegylated interferon alpha-2b.
    Wang YS; Youngster S; Bausch J; Zhang R; McNemar C; Wyss DF
    Biochemistry; 2000 Sep; 39(35):10634-40. PubMed ID: 10978146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting interferon-alpha 2a modified with a trimer-structured polyethylene glycol: preparation, in vitro bioactivity, in vivo stability and pharmacokinetics.
    Jo YW; Youn YS; Lee SH; Kim BM; Kang SH; Yoo M; Choi EC; Lee KC
    Int J Pharm; 2006 Feb; 309(1-2):87-93. PubMed ID: 16406701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of exenatide analogue mono-PEGylated with 40 kDA polyethylene glycol by cation exchange chromatography.
    Cai Y; Yue P
    J Chromatogr A; 2011 Sep; 1218(39):6953-60. PubMed ID: 21862025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of improved antibody aggregate separation in polyethylene glycol-modulated cation exchange chromatography.
    Kluters S; Neumann S; von Hirschheydt T; Grossmann A; Schaubmar A; Frech C
    J Sep Sci; 2012 Nov; 35(22):3130-8. PubMed ID: 23111946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of arginine as an efficient eluent in cation exchange chromatographic purification of a PEGylated peptide.
    Annathur GV; Buckley JJ; Muthurania K; Ramasubramanyan N
    J Chromatogr A; 2010 Jun; 1217(24):3783-93. PubMed ID: 20447639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Length and Structure of Attached Polyethylene Glycol Chain on Hydrodynamic Radius, and Separation of PEGylated Human Serum Albumin by Chromatography.
    Akbarzadehlaleh P; Mirzaei M; Mashahdi-Keshtiban M; Heidari HR
    Adv Pharm Bull; 2021 Sep; 11(4):728-738. PubMed ID: 34888220
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation and characterization of monopegylated human granulocyte-macrophage colony-stimulating factor.
    Lee DL; Sharif I; Kodihalli S; Stewart DI; Tsvetnitsky V
    J Interferon Cytokine Res; 2008 Feb; 28(2):101-12. PubMed ID: 18279105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of a pegylated interferon-alpha2a product by a customised and validated reverse phase-high performance liquid chromatography method.
    El Ghazaly M; Meager A; Zikry H; Ebaed M; Shaker S; Mueller F; Rohde J
    J Pharm Biomed Anal; 2013 Oct; 84():48-52. PubMed ID: 23797040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.